Aspargo Labs, Inc
Clinical trials sponsored by Aspargo Labs, Inc, explained in plain language.
-
New sildenafil sprays tested for faster absorption
Symptom relief Not yet recruitingThis early-stage study tests two new sildenafil formulations (Hezkue and Hezkue Turbo) against existing products in 72 healthy men aged 18-70. The goal is to see how quickly and safely each is absorbed after a meal. Results will help determine if these new versions offer any adva…
Phase: PHASE1 • Sponsor: Aspargo Labs, Inc • Aim: Symptom relief
Last updated Apr 26, 2026 20:03 UTC
-
Liquid metformin: easier on the stomach?
Knowledge-focused Not yet recruitingThis study tests whether liquid metformin causes fewer stomach side effects than standard tablets. Twenty-four healthy adults will try both forms and report any discomfort. The goal is to find a better-tolerated option for people who need metformin.
Phase: PHASE1 • Sponsor: Aspargo Labs, Inc • Aim: Knowledge-focused
Last updated May 01, 2026 16:00 UTC
-
Liquid metformin: easier to swallow?
Knowledge-focused Not yet recruitingThis study tests a new liquid version of the diabetes drug metformin to see how well it is absorbed compared to standard tablets. Twenty-four healthy adults will take both forms in random order, with blood samples collected to measure drug levels. The goal is to gather informatio…
Phase: PHASE1 • Sponsor: Aspargo Labs, Inc • Aim: Knowledge-focused
Last updated May 01, 2026 16:00 UTC
-
Liquid metformin: a new option for diabetes?
Knowledge-focused Not yet recruitingThis study aims to see if a liquid form of metformin is as effective as the standard tablet form. It will involve 24 healthy adults who will take both versions at different times. Researchers will measure drug levels in the blood to compare how the body processes each form.
Phase: PHASE1 • Sponsor: Aspargo Labs, Inc • Aim: Knowledge-focused
Last updated May 01, 2026 15:59 UTC
-
Liquid metformin: easier to swallow?
Knowledge-focused Not yet recruitingThis study looks at how two liquid forms of metformin (a common diabetes medicine) are absorbed by the body compared to regular tablets. It involves 24 healthy adults aged 18 to 55. The goal is to measure drug levels in the blood, not to treat any disease.
Phase: PHASE1 • Sponsor: Aspargo Labs, Inc • Aim: Knowledge-focused
Last updated May 01, 2026 15:58 UTC
-
Liquid metformin put to the test against standard pills
Knowledge-focused Not yet recruitingThis early-stage study tests how two different liquid forms of metformin affect blood sugar compared to regular metformin tablets. Twenty-four healthy adults will take single or short-term doses of each version in a random order. Researchers will measure blood sugar levels and ch…
Phase: PHASE1 • Sponsor: Aspargo Labs, Inc • Aim: Knowledge-focused
Last updated Apr 28, 2026 13:02 UTC